Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11207545 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7624634 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL15132444 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL20859564 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL13327139 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL7620280 | 1.00 | HDAC3 (0.53) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Bromide SCHEMBL12231024 | 0.98 | HDAC3 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Bromide SCHEMBL10991505 | 0.98 | HDAC3 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Bromide SCHEMBL7743168 | 0.98 | HDAC3 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| Bromide SCHEMBL28278964 | 0.98 | HDAC3 (0.52) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118986934-B | Sodium pyruvate sustained-release nano system based on targeted modification and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-117770450-B | High-purity capsaicin composition, and preparation method and application thereof | 天津福来特新材料科技有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-117659113-A | Cholic alcohol and triphenylphosphine group modified asymmetric axial substituted silicon (IV) phthalocyanine and preparation method and application thereof | 福建师范大学 | 2024-03-08 | — | — | CN | claimed |
| CN-117244058-A | Ferritin composite system loaded with novel triphenylphosphine substituted silicon (IV) phthalocyanine complex and application thereof | 福州量衍科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-115212188-B | Ischemic brain region targeted nanowire mitochondria and preparation method and application thereof | 西安交通大学医学院第一附属医院 | 2023-04-07 | — | — | CN | claimed |
| CN-115184420-A | Preparation method of hemoglobin biosensor based on carboxyl functionalized phosphine-based ionic liquid @ multi-walled carbon nanotube | 天津科技大学 | 2022-10-14 | — | — | CN | claimed |
| US-20250235805-A1 | LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS | TOKUYAMA CORPORATION (JP) | 2025-07-24 | — | — | US | disclosed |
| US-20250215574-A1 | SEMICONDUCTOR TREATMENT LIQUID FOR REMOVING RUTHENIUM SILICIDE | TOKUYAMA CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-119948603-A | Dry etching residue removing liquid | 株式会社德山 | 2025-05-06 | — | — | CN | disclosed |
| US-20250084309-A1 | SEMICONDUCTOR PROCESSING SOLUTION | TOKUYAMA CORPORATION (JP) | 2025-03-13 | — | — | US | disclosed |
| CN-119592142-A | Natural antibacterial film-coating fresh-keeping material and preparation method and application thereof | 中国热带农业科学院南亚热带作物研究所 | 2025-03-11 | — | — | CN | disclosed |
| EP-4506982-A1 | LUBRICANT FOR FILTRATION CONTAINING ONIUM IONS | TOKUYAMA CORPORATION (JP) | 2025-02-12 | — | — | EP | disclosed |
| EP-4472948-A2 | NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF | New Frontier Bio, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| CN-1224624-C | 1, 8-naphthyridin-2 (1H) -one derivatives | GRELAN PHARMACEUTICAL CO (JP) | 2005-10-26 | — | — | CN | disclosed |
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| EP-1424336-A1 | 1,3-BENZOTHIAZINONE DERIVATIVES AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2004-06-02 | — | — | EP | disclosed |
| CN-1407984-A | Novel 1, 8-naphthyridin-2 (1H) -one derivatives | GRELAN PHARMACEUTICAL CO (JP) | 2003-04-02 | — | — | CN | disclosed |
| CN-1015893-B | 1,3-DIOXANES | ICI LTD (GB) | 1992-03-18 | — | — | CN | disclosed |
| CN-88102356-A | 1,3-two alkanes | — | 1988-12-28 | — | — | CN | disclosed |
| US-4029681-A | 13,14-Didehydro-PG analogs | THE UPJOHN COMPANY (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050032786-A1 | 1, 3-benzothiazinone derivatives and use thereof | MIF, MORF4L1, FOXM1 | HDAC3 1248/4885HDAC4 987/4885HDAC1 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.